CAU
VRNA

Caxton Associates (UK)’s Verona Pharma VRNA Stock Holding History

Caxton Associates (UK)’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$3.38M Buy
+35,716
New +$3.38M 0.09% 115